
HIV Protease
Os inibidores da protease do HIV são uma classe de medicamentos antirretrovirais que têm como alvo específico a enzima protease do vírus da imunodeficiência humana (HIV). Ao inibir esta enzima, esses compostos impedem o vírus de processar suas poliproteínas em proteínas maduras e funcionais, bloqueando assim a produção de novos virions infecciosos. Os inibidores da protease do HIV são um pilar da terapia antirretroviral altamente ativa (HAART) utilizada para o tratamento do HIV/AIDS. Na CymitQuimica, oferecemos uma variedade de inibidores da protease do HIV para apoiar sua pesquisa em tratamento do HIV, resistência a medicamentos e virologia.
Foram encontrados 447 produtos de "HIV Protease"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
HIV-1 inhibitor-31
CAS:<p>HIV-1 inhibitor-31 (compound 4) is a potent inhibitor of HIV-1. HIV-1 inhibitor-31 can be used in the study of AIDS.</p>Fórmula:C21H13Cl2N3O2Cor e Forma:SolidPeso molecular:410.25Deaminase inhibitor-1
CAS:<p>Deaminase inhibitor-1 is an APOBEC3G DNA Deaminase inhibitor with an IC 50 value of 18.9 μM [1].</p>Fórmula:C11H12BrN3OSCor e Forma:SolidPeso molecular:314.2HIV-1 inhibitor-50
CAS:<p>HIV-1 inhibitor-50 is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that targets HIV-1 reverse transcriptase (IC50 = 50 nM).</p>Fórmula:C24H18FN5O2Cor e Forma:SolidPeso molecular:427.43S-1360
CAS:<p>S-1360 is an inhibitor of HIV-1 integrase.</p>Fórmula:C16H12FN3O3Pureza:98%Cor e Forma:SolidPeso molecular:313.28PF-46396
CAS:<p>PF-46396 is a HIV maturation inhibitor and can be used against HIV-1 clade B and C.</p>Fórmula:C27H29F3N2OCor e Forma:SolidPeso molecular:454.53HIV-1 inhibitor-39
CAS:<p>HIV-1 inhibitor-39: blocks HIV-1, anti-RT (IC50=15.75 μM), toxic to MT-4 cells (CC50=112.9 μM).</p>Fórmula:C20H17ClN4O4S4Cor e Forma:SolidPeso molecular:541.09HIV-1 inhibitor-48
CAS:<p>HIV-1 inhibitor-48 is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) and exhibits anti-HIV-1 activity .</p>Fórmula:C19H16BrN5Cor e Forma:SolidPeso molecular:394.27HIV-1 inhibitor-35
CAS:<p>HIV-1 inhibitor-35, potent against HIV (EC50: 80 nM LTR, 70 nM CMV), also suppresses HepG2 cells (CC50: 40 nM), may reverse HIV-1 latency.</p>Fórmula:C13H12Cl3N5OSCor e Forma:SolidPeso molecular:392.69HIV-1 inhibitor-9
CAS:<p>HIV-1 inhibitor-9 potently blocks WT and NNRTI-resistant HIV strains at low nanomolar levels.</p>Fórmula:C24H21N5OCor e Forma:SolidPeso molecular:395.46HIV-1 inhibitor-56
CAS:<p>HIV-1 inhibitor-56 (compound 12126065) is a potent non-nucleoside reverse transcriptase inhibitor with significant antiviral activity against wild-type HIV-1,</p>Fórmula:C22H14ClN7O2SCor e Forma:SolidPeso molecular:475.91Cgp 53820
CAS:<p>CGP 53820 is a pseudosymmetric inhibitor of HIV-1 Protease.</p>Fórmula:C31H51N5O5Cor e Forma:SolidPeso molecular:573.77HIV-1 inhibitor-33
CAS:<p>HIV-1 inhibitor-33, potent against HIV-1 (EC50: 8.6 nM), low toxicity to MT-4 cells (CC50: 18 μM), useful for AIDS research.</p>Fórmula:C25H28N6OCor e Forma:SolidPeso molecular:428.53ML67-33
CAS:<p>ML67-33 selectively activates K2P channels; EC50: 36.3 μM (cell-free), 9.7 μM (HEK293). Reversible TREK-1 modulation.</p>Fórmula:C18H17Cl2N5Pureza:98%Cor e Forma:SolidPeso molecular:374.27HEPT
CAS:<p>HEPT is a non-nucleoside inhibitor of HIV-1 reverse transcription.</p>Fórmula:C14H16N2O4SPureza:98%Cor e Forma:SolidPeso molecular:308.35L-Ristosamine nucleoside
CAS:<p>L-Ristosamine nucleoside shows antiviral activity.</p>Fórmula:C21H21N3O7Cor e Forma:SolidPeso molecular:427.41Suberosol
CAS:<p>Suberosol possesses anti-HIV replication activity.</p>Fórmula:C31H50O2Pureza:98%Cor e Forma:SolidPeso molecular:454.73ZP7
CAS:<p>ZP7 is a HIV-1 replication inhibitor.</p>Fórmula:C15H9Br2ClN4OS2Pureza:98%Cor e Forma:SolidPeso molecular:520.65APA-APA-MPO
CAS:<p>APA-APA-MPO is a PCAF bromodomain/Tat-AcK50 association inhibitor.</p>Fórmula:C12H25Cl2N5OPureza:98%Cor e Forma:SolidPeso molecular:326.27Ingenol 3-Hexanoate
CAS:<p>Ingenol 3-Hexanoate is a novel potent reactivator of latent HIV-1.</p>Fórmula:C26H38O6Pureza:98%Cor e Forma:SolidPeso molecular:446.58BM 21.1298
CAS:<p>BM 21.1298 is a inhibition of HIV-1 reverse transcriptase.</p>Fórmula:C16H13NOSPureza:98%Cor e Forma:SolidPeso molecular:267.35D4DAP
CAS:<p>D4DAP is an inhibitor of HIV virus replication.</p>Fórmula:C10H12N6O2Pureza:98%Cor e Forma:SolidPeso molecular:248.24Nitrobenzofuroxan
CAS:<p>Nitrobenzofuroxan, is a HIV-1 and IDO1 inhibitor.</p>Fórmula:C6H3N3O4Pureza:98%Cor e Forma:SolidPeso molecular:181.11BMS-663749 lysine
CAS:<p>BMS-663749 lysine is used as a phosphonooxymethyl prodrug 4 for HIV-1 attachment inhibitor.</p>Fórmula:C29H39N6O11PPureza:98%Cor e Forma:SolidPeso molecular:678.63GSK5750
CAS:<p>GSK5750 is the ribonuclease H activity inhibitor.</p>Fórmula:C16H12N4O2SCor e Forma:SolidPeso molecular:324.365-Et-ddU
CAS:<p>5-Et-ddU: A pyrimidine nucleoside with anti-HIV-1 activity in human blood cells.</p>Fórmula:C11H16N2O4Pureza:98%Cor e Forma:SolidPeso molecular:240.26L-708906
CAS:<p>L-708906 is the Human Immunodeficiency Virus Type 1 inhibitor.</p>Fórmula:C24H20O6Pureza:98%Cor e Forma:SolidPeso molecular:404.41Dacopafant
CAS:<p>Dacopafant is an antagonist of platlet activationg factor receptor.</p>Fórmula:C12H11N3OSCor e Forma:SolidPeso molecular:245.35M038
CAS:<p>5M038, a novel inhibitor of HIV envelope-mediated fusion, strongly inhibits gp41-mediated membrane fusion.</p>Fórmula:C17H8F6N4Pureza:98%Cor e Forma:SolidPeso molecular:382.26L 738372
CAS:<p>L 738372 is a non-nucleoside inhibitor of HIV-1 reverse transcriptase.</p>Fórmula:C18H15N3OCor e Forma:SolidPeso molecular:289.33Vif-A3G Inhibitor N.41
CAS:<p>Vif-A3G Inhibitor N.41 is a HIV-1 inhibitor-targeting drug. It causes Vif-dependent degradation of human APOBEC3G, thereby inhibiting the Vif-A3G interaction.</p>Fórmula:C15H14N2O2Pureza:98%Cor e Forma:SolidPeso molecular:254.28A 75925
CAS:<p>A 75925, a nonnucleoside reverse transcriptase inhibitors (NNRTI), works to inhibit HIV-1 replication.</p>Fórmula:C44H54N4O8Pureza:98%Cor e Forma:SolidPeso molecular:766.92HIV-1 inhibitor-53
CAS:<p>HIV-1 Inhibitor-53 targets HIV-1 protease (IC50: 1.93 nM) and reverse transcriptase (IC50: 2.35 μM), aiding AIDS research.</p>Fórmula:C30H34N2O8SPureza:98%Cor e Forma:SolidPeso molecular:582.66Fosdevirine
CAS:<p>Fosdevirine (GSK2248761), a non-nucleoside reverse transcriptase (NNRTI) inhibitor with anti-HIV activity, is used in the study of neurological related diseases</p>Fórmula:C20H17ClN3O3PPureza:99.92%Cor e Forma:SolidPeso molecular:413.79(S)-BI-1001
CAS:<p>(S)-BI-1001 is an active S-enantiomer of BI-1001. (S)-BI-1001 has antiviral potency against HIV-1 integrase (IC50: 28 nM, and EC50: 450 nM and a Kd: 4.7 μM).</p>Fórmula:C19H15BrClNO3Pureza:98%Cor e Forma:SolidPeso molecular:420.68Navuridine
CAS:<p>Navuridine (AZdU) is an oral active inhibitor of HIV reverse transcriptase with a relatively short half-life.</p>Fórmula:C9H11N5O4Pureza:99.83%Cor e Forma:SolidPeso molecular:253.22Isoescin IA
CAS:<p>Isoescin IA is a triterpenoid saponin isolated from the seeds of Aesculus chinensis. It has anti-HIV-1 protease activity.</p>Fórmula:C55H86O24Pureza:96.00%Cor e Forma:SolidPeso molecular:1131.26L 756423
CAS:<p>L756423 is a potent, selective HIV protease inhibitor (Ki=0.049 nM), effective against HIV spread in MT25 lymphocytes at 0.1-0.5 nM, useful for AIDS research.</p>Fórmula:C39H48N4O5Pureza:99.34% - 99.88%Cor e Forma:SolidPeso molecular:652.82Opaviraline
CAS:<p>Opaviraline (GW-420867X) is a potent reverse transcriptase inhibitor that inhibits Human immunodeficiency virus 1 and has the potential to treat HIV infection.</p>Fórmula:C14H17FN2O3Pureza:99.94%Cor e Forma:SolidPeso molecular:280.29Emivirine
CAS:<p>Emivirine (MKC-442) is a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1.</p>Fórmula:C17H22N2O3Pureza:99.8%Cor e Forma:SolidPeso molecular:302.37GSK-364735
CAS:<p>GSK-364735 is an HIV-1 IN inhibitor.</p>Fórmula:C19H18FN3O4Pureza:97.73%Cor e Forma:SolidPeso molecular:371.36Lenacapavir
CAS:<p>Lenacapavir (GS-6207) is the first HIV-1 capsid inhibitor approved by the U.S. Food and Drug Administration, the European Medicines Agency, and Health Canada for the treatment of MDR HIV-1 infection.Cost-effective and quality-assured.</p>Fórmula:C39H32ClF10N7O5S2Pureza:99.61% - 99.87%Cor e Forma:SolidPeso molecular:968.28AzddMeC
CAS:<p>AzddMeC (Az-Dcme) is an HIV-1 reverse transcriptase and HIV-1 replication inhibitor with antiretroviral activity.AzddMeC is used in the study of HIV-1 infection</p>Fórmula:C10H14N6O3Pureza:97.14% - 99.62%Cor e Forma:SolidPeso molecular:266.26HIV-1 integrase inhibitor 8
CAS:<p>HIV-1 integrase inhibitor 8 is an inhibitor of HIV-1 integrase. Integration is a required step in HIV replication [1].</p>Fórmula:C21H24O2Pureza:98.91%Cor e Forma:SolidPeso molecular:308.41KM-023
CAS:<p>KM-023 is a new second-generation non-nucleoside reverse transcriptase inhibitor for the study of human immunodeficiency virus (HIV) type 1 infection.</p>Fórmula:C18H19N3O3Pureza:99.47% - >99.99%Cor e Forma:SolidPeso molecular:325.36BMS-488043
CAS:<p>BMS-488043 is a novel and unique oral small molecule HIV fusion inhibitor that inhibits the attachment of Human Immunodeficiency Virus type 1 (HIV-1) to CD4(+)</p>Fórmula:C22H22N4O5Pureza:99.95%Cor e Forma:SolidPeso molecular:422.43(2RS)-FPMPA
CAS:<p>(2RS)-FPMPA(FPMPA) has antiviral activity with an IC50 value of 1.85 μM measured in human MT12 cells infected with SHIV (DH4R).</p>Fórmula:C9H13FN5O4PPureza:99.9% - >99.99%Cor e Forma:SolidPeso molecular:305.2Tenofovir alafenamide fumarate
CAS:<p>Tenofovir alafenamide fumarate (GS-7340) is an oral anti-HIV drug that prevents infection.</p>Fórmula:C25H33N6O9PPureza:99.95%Cor e Forma:SolidPeso molecular:592.54Atevirdine
CAS:<p>Atevirdine is an HIV-1 reverse transcriptase inhibitor with antiviral activity for the study of the AIDS dementia complex (ADC).</p>Fórmula:C21H25N5O2Pureza:98.20%Cor e Forma:SolidPeso molecular:379.46Suksdorfin
CAS:<p>Suksdorfin has hypoglycemic effects and activates PPARγ, which promotes insulin-dependent glucose uptake by adipocytes and can be used to study obesity .</p>Fórmula:C21H24O7Pureza:98.54%Cor e Forma:SolidPeso molecular:388.41KNI-272
CAS:<p>Kynostatin-272 is a HIV protease inhibitor. KNI-272 blocked the maturation of viral particles.</p>Fórmula:C33H41N5O6S2Cor e Forma:SolidPeso molecular:667.84DMP 323
CAS:<p>DMP 323 is a potent inhibitor of HIV-1 protease.</p>Fórmula:C35H38N2O5Pureza:98%Cor e Forma:SolidPeso molecular:566.69Berlopentin
CAS:<p>Berlopentin is splenopentin analog used to treat HIV-positive patients. It also has immunostimulatory properties.</p>Fórmula:C35H55N9O11Cor e Forma:SolidPeso molecular:777.86Capravirine
CAS:<p>Capravirine, a non-nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.</p>Fórmula:C20H20Cl2N4O2SPureza:98%Cor e Forma:SolidPeso molecular:451.37L-697661
CAS:<p>L-697661, a reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.</p>Fórmula:C16H15Cl2N3O2Cor e Forma:SolidPeso molecular:352.22A 77003
CAS:<p>A 77003 is a HIV-1 protease inhibitor. A77003 impairs HIV-1 protease-mediated Gag processing.</p>Fórmula:C44H58N8O6Cor e Forma:SolidPeso molecular:794.98PYR01
CAS:<p>PYR01 is a potent nonnucleoside reverse transcriptase inhibitor of HIV-1 and concurrently acts as a targeted activator to eliminate cells expressing HIV-1 [1].</p>Fórmula:C21H13F7N4O3Cor e Forma:SolidPeso molecular:502.34Indinavir, threo-
CAS:<p>Indinavir, threo- is a protease inhibitor utilized as a component of highly active antiretroviral treatment to HIV/AIDS.</p>Fórmula:C36H47N5O4Pureza:98%Cor e Forma:SolidPeso molecular:613.79A 74704
CAS:<p>A 74704 is a pseudo C2-symmetric inhibitor of HIV-1 protease and its diester analog.</p>Fórmula:C43H52N4O7Pureza:98%Cor e Forma:SolidPeso molecular:736.9BMS-561390
CAS:<p>BMS-561390, a reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.</p>Fórmula:C14H12ClF3N2OCor e Forma:SolidPeso molecular:316.71Droxinavir HCl
CAS:<p>Droxinavir HCl is an antiviral agent and HIV protease inhibitor.</p>Fórmula:C29H52ClN5O4Pureza:98%Cor e Forma:SolidPeso molecular:570.22Bavtavirine
CAS:<p>Bavtavirine is a non-nucleoside reverse HIV-1 transcriptase inhibitor (NNRTIs),inhibits HIV replication by preventing the transcription of viral RNA into DNA.</p>Fórmula:C26H20N6Pureza:97.2%Cor e Forma:SolidPeso molecular:416.48HIV-1 inhibitor-10
CAS:<p>HIV-1 inhibitor-10 is a nanomolar HIV-1 maturation inhibitor.</p>Fórmula:C39H54O6Cor e Forma:SolidPeso molecular:618.84U 104489
CAS:<p>U 104489 (PNU-104489) is a novel specific inhibitor of human immunodeficiency virus 1 (HIV-1), showing effective activity against BHA-P-resistant HIV-1MF.</p>Fórmula:C26H36N6O3SCor e Forma:SolidPeso molecular:512.67U 89360E
CAS:<p>U 89360E is a peptidic inhibitor.</p>Fórmula:C28H52N8O6Pureza:98%Cor e Forma:SolidPeso molecular:596.76Palinavir
CAS:<p>Palinavir is an antiviral, it inhibits HIV-1 protease.</p>Fórmula:C41H52N6O5Pureza:98%Cor e Forma:SolidPeso molecular:708.89BILR-355
CAS:<p>BILR-355 is a reverse transcriptase inhibitor.</p>Fórmula:C25H23N5O3Pureza:98%Cor e Forma:SolidPeso molecular:441.48XZ426
CAS:<p>XZ426 is a potent integrase strand transfer inhibitor with anti- HIV activity .</p>Fórmula:C22H24F2N4O4Cor e Forma:SolidPeso molecular:446.45HIV-1 integrase inhibitor 3
CAS:<p>HIV-1 integrase inhibitor 3 is an HIV-1 integrase strand transfer (INST) inhibitor (IC50: 2.7 nM).</p>Fórmula:C21H22F2N4O4Pureza:98%Cor e Forma:SolidPeso molecular:432.427-Deaza-2',3'-dideoxyguanosine
CAS:<p>7-Deaza-2',3'-dideoxyguanosine (7-Deaza-ddG) is a 2′,3′-dideoxynucleoside 5′-triphosphate that inhibits HIV-1 reverse transcriptase with a Ki of 25 nM [1].</p>Fórmula:C11H14N4O3Cor e Forma:SolidPeso molecular:250.25GSK3532795
CAS:<p>GSK3532795: potent oral HIV-1 maturation inhibitor; EC50: 1.9-13 nM for various strains.</p>Fórmula:C42H62N2O4SPureza:98%Cor e Forma:SolidPeso molecular:691.02L-696229
CAS:<p>L-696229: specific HIV-1 RT inhibitor, blocks viral spread in various cells.</p>Fórmula:C17H18N2O2Pureza:98%Cor e Forma:SolidPeso molecular:282.34Murabutide
CAS:<p>Murabutide, a safe synthetic immunomodulator, diminishes the expression of CD4 and CCR5 receptors and promotes the secretion of high levels of beta-chemokines,</p>Fórmula:C23H40N4O11Cor e Forma:SolidPeso molecular:548.58L-689502
CAS:<p>L-689502 is a potent HIV-l protease inhibitor (IC50: 1 nM).</p>Fórmula:C39H51N3O7Pureza:98%Cor e Forma:SolidPeso molecular:673.84Fosalvudine tidoxil
CAS:<p>Fosalvudine tidoxil, a nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.</p>Fórmula:C35H64FN2O8PSPureza:98%Cor e Forma:SolidPeso molecular:722.93GSK3839919A
CAS:<p>GSK3839919A is a potent allosteric inhibitor of HIV-1 integrase [1].</p>Fórmula:C36H46ClN3O3Cor e Forma:SolidPeso molecular:604.22Reverse transcriptase-IN-1
CAS:<p>Reverse transcriptase-IN-1 is a diarylbenzopyrimidine (DABP) analogue and a potent inhibitor of HIV-1 nonnucleoside reverse transcriptase with an IC50of 13.7</p>Fórmula:C25H17N7O2Pureza:99.61%Cor e Forma:SolidPeso molecular:447.45Hinokinin
CAS:<p>Hinokinin (Cubebinolide), a bioactive lignan, exhibits a broad spectrum of pharmacological activities.</p>Fórmula:C20H18O6Cor e Forma:SolidPeso molecular:354.35HIV-1 inhibitor-3
CAS:<p>HIV-1 inhibitor-3 is an HIV infection inhibitor.</p>Fórmula:C9H10F2N2O5Pureza:98%Cor e Forma:SolidPeso molecular:264.18HIV-1 protease-IN-11
CAS:<p>HIV-1 protease-IN-11 (compound 34a), an HIV-1 protease inhibitor, demonstrates potent inhibition with an IC50 of 0.41 nM and maintains substantial efficacy</p>Fórmula:C26H37N3O5SPureza:98%Cor e Forma:SolidPeso molecular:503.65HIV-1 protease-IN-8
CAS:<p>HIV-1 protease-IN-8 (compound 34b) is a potent inhibitor of the HIV-1 protease enzyme, exhibiting an IC50 of 0.32 nM.</p>Fórmula:C25H35N3O5SPureza:98%Cor e Forma:SolidPeso molecular:489.63HIV-1 protease-IN-7
CAS:<p>HIV-1 protease-IN-7 (compound 16) is an orally active inhibitor of HIV-1 protease, exhibiting an IC50 of 3.52 nM and an EC50 of 37 nM [1].</p>Fórmula:C68H104N10O12SPureza:98%Cor e Forma:SolidPeso molecular:1285.68HIV-1 protease-IN-12
CAS:<p>HIV-1 protease-IN-12 (compound 35b) serves as a potent inhibitor of HIV-1 protease, exhibiting an IC50 value of 0.51 nM, and demonstrates efficacy against drug-</p>Fórmula:C25H35N3O5SPureza:98%Cor e Forma:SolidPeso molecular:489.63HIV-1 protease-IN-9
CAS:<p>HIV-1 protease-IN-9 (compound 5b), a potent HIV-1 protease inhibitor, exhibits strong antiviral efficacy with a dissociation constant (K_i) of 0.028 nM and a</p>Fórmula:C37H41N7O4SPureza:98%Cor e Forma:SolidPeso molecular:679.83NNRTIs-IN-1
CAS:<p>NNRTIs-IN-1 is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI) with notable anti-resistance efficacy, effectively inhibiting both the wild-type</p>Fórmula:C28H22N6O3Cor e Forma:SolidPeso molecular:490.51L 687908
CAS:<p>L 687908 is a potent inhibitor of hydroxyethylene-containing HIV protease.</p>Fórmula:C40H51N5O5Pureza:98%Cor e Forma:SolidPeso molecular:681.86HIV-IN-8
CAS:<p>HIV-IN-8 (Compound 9) acts as an HIV inhibitor, suppressing HIV replication with an effective concentration (EC50) of 13 μg/mL [1].</p>Fórmula:C36H30O16Cor e Forma:SolidPeso molecular:718.61PNU-103017
CAS:<p>PNU-103017 is an inhibitor of HIV protease.</p>Fórmula:C28H28N2O5SPureza:98%Cor e Forma:SolidPeso molecular:504.6R 87366
CAS:<p>R 87366 is used as a water-soluble HIV protease inhibitor.</p>Fórmula:C32H39N7O6Pureza:98%Cor e Forma:SolidPeso molecular:617.7L 694746
CAS:<p>L 694746 is an inhibitor of HIV-1 protease.</p>Fórmula:C35H42N2O8Pureza:98%Cor e Forma:SolidPeso molecular:618.72DGKα-IN-8
CAS:<p>DGKα-IN-8 (Example 51) is a potent diacylglycerol kinase alpha (DGKα) inhibitor, exhibiting an IC50 of 22.491 nM and an EC50 of 0.256 nM.</p>Fórmula:C23H19ClF3N5OCor e Forma:SolidPeso molecular:473.88I-XW-053
CAS:<p>I-XW-053 is an inhibitor of capsid targeted HIV-1 replication using the hybrid structure based method to block the interface between CA N-terminal domains (NTD-</p>Fórmula:C22H16N2O2Pureza:99.05%Cor e Forma:SolidPeso molecular:340.37Ulonivirine
CAS:<p>Ulonivirine is an orally active non-nucleoside reverse transcriptase inhibitor that exhibits high antiviral activity and can be used to study HIV-1 infection.</p>Fórmula:C18H8ClF6N5O3Cor e Forma:SolidPeso molecular:491.73Teropavimab
CAS:<p>Teropavimab (3BNC117-LS), an antibody, is utilized in the research of HIV infection [1].</p>Cor e Forma:LiquidRo 31-8588
CAS:<p>Talviraline (HBY 097) inhibits HIV-1 replication and reduces cell death in various cells and immune cells.</p>Fórmula:C33H56N4O5Cor e Forma:SolidPeso molecular:588.82Azt-pmap
CAS:<p>AZT-PMPA, an aryl phosphate derivative of AZT and a nucleoside analogue, demonstrates anti-HIV activity[1].</p>Fórmula:C20H25N6O8PPureza:98%Cor e Forma:SolidPeso molecular:508.42WRNA10
CAS:<p>WRNA10 is a potent binding agent for HIV-1TAR RNA (IC50: 10 μM, CC50: 40 μM).</p>Fórmula:C25H32N4O4Cor e Forma:SolidPeso molecular:452.55Glycolithocholic acid 3-sulfate disodium
CAS:<p>Glycolithocholic acid 3-sulfate (disodium) demonstrates inhibitory effects on in vitro HIV-1 replication and has potential applications in HIV infection and</p>Fórmula:C26H41NNa2O7SCor e Forma:SolidPeso molecular:557.65HIV-1 inhibitor-54
CAS:<p>HIV-1 inhibitor-54: potent anti-HIV (EC50: 32 nM), targets WT HIV-1 IIIB in MT-4 cells for infection research.</p>Fórmula:C27H30N6O4SPureza:98.05% - 99.44%Cor e Forma:SoildPeso molecular:534.63PDDC inhibitor
CAS:<p>PDDC inhibitor (Phenyl (R)-(1-(3-(3,4-dimethoxyphenyl)-2,6-dimethylimidazo[1,2-b]pyridazin-8-yl)pyrrolidin-3-yl)carbamate) is an nSMase2 inhibitor.</p>Fórmula:C27H29N5O4Pureza:96.09% - 99.39%Cor e Forma:SolidPeso molecular:487.55HIV-1 inhibitor-17
<p>HIV-1 inhibitor-18 blocks HIV-1 capsid, acts on NL4-3 strain (EC50: 2.57 μM), has low cytotoxicity (MT-4 CC50: >8.55).</p>Fórmula:C32H32N4O5SCor e Forma:SolidPeso molecular:584.69

